Results 11 to 20 of about 749,314 (382)

Acute myeloid leukemia

open access: yesHemaSphere, 2018
Advances in our understanding of the pathophysiology of acute myeloid leukemia (AML) have not yet led to major improvements in disease-free and overall survival of adults with this disease.
G. Ossenkoppele
semanticscholar   +3 more sources

Chronic Myeloid Leukemia [PDF]

open access: yesHematology, 2003
AbstractChronic myeloid leukemia (CML) was the first human malignancy to be associated with a specific genetic lesion, the Philadelphia chromosome, harboring the BCR-ABL oncogene. Since then, it has become a paradigm for the discovery of molecular mechanisms and targeted therapeutic approaches in the field of hematologic neoplasias. The past 5 years or
Junia V. Melo   +2 more
openaire   +5 more sources

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Older patients with acute myeloid leukemia (AML) have a dismal prognosis, even after treatment with a hypomethylating agent. Azacitidine added to venetoclax had promising efficacy in a previous phase 1b study.
C. Dinardo   +29 more
semanticscholar   +1 more source

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

open access: yesLeukemia, 2020
The therapeutic landscape of chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients with chronic phase (CP) now have a normal life expectancy.
A. Hochhaus   +33 more
semanticscholar   +1 more source

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.

open access: yesThe Journal of the National Comprehensive Cancer Network, 2021
The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding ...
D. Pollyea   +33 more
semanticscholar   +1 more source

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

open access: yesBlood, 2016
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid ...
D. Arber   +8 more
semanticscholar   +1 more source

Acute myeloid leukemia: update in diagnosis and treatment in Brazil [PDF]

open access: yesEinstein (São Paulo), 2011
Objective: To identify how the Brazilian hematology centers treated and diagnosed cases of acute myeloid leukemia in 2009. Methods: An epidemiological observational multicenter study of 11 listed Brazilian centers that treat acute myeloid leukemia and ...
Ricardo Helman   +12 more
doaj   +3 more sources

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017

open access: yesCancer, 2021
Several important treatment and supportive care strategies have been implemented over the past 4 decades in the management of acute myeloid leukemia (AML).
K. Sasaki   +7 more
semanticscholar   +1 more source

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

open access: yesNew England Journal of Medicine, 2016
BACKGROUND Recent studies have provided a detailed census of genes that are mutated in acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity defines the pathophysiology of AML and informs clinical practice ...
E. Papaemmanuil   +26 more
semanticscholar   +1 more source

YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.

open access: yesBlood, 2021
RNA-binding proteins (RBPs) are critical regulators of transcription and translation that are often dysregulated in cancer. Although RBPs are increasingly appreciated as being important for normal hematopoiesis and for hematological malignancies as ...
Mengdie Feng   +24 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy